From the Star:
“By 2013, the Public Health Agency, backed by the Department of National Defence, had spent $887,000 to have a German company, IDT Biologika, manufacture 1,500 vials of VSV-EBOV suitable for human trials.
It is this stockpile that is slated for use in trials planned for Europe, Africa, the U.S. and Canada.
In short, he Canadian government not only sold off commercial rights to its Ebola vaccine to a for-profit firm at sale-price rates. It also paid the lion’s share of costs required to test the vaccine for human use.
But then everything around this vaccine has been unusual.
It was developed not by some grand government design but because, as Helen Branswell of The Canadian Press has written, scientists attracted to the Winnipeg lab in the early years of the century happened to be interested in and knowledgeable about Ebola.
The vaccine was patented in 2003 and…
View original post 36 more words